Does Rallies show 13F holders for BTSG?

Yes. Rallies tracks hedge fund and 13F ownership data for BTSG, including fund names, share counts, latest tracked quarter, and position changes when available.

Is BTSG research on Rallies investment advice?

No. Rallies provides research, data, and educational context for BTSG. It does not provide personalized investment advice.

BTSG (BrightSpring Health Services, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

BrightSpring Health Services, Inc. Common Stock (BTSG) is a publicly traded Healthcare sector company. As of May 21, 2026, BTSG trades at $58.92 with a market cap of $10.89B and a P/E ratio of 38.48. BTSG moved +3.23% today. Year to date, BTSG is +49.24%; over the trailing twelve months it is +145.97%. Its 52-week range spans $14.03 to $59.00. Analyst consensus is strong buy with an average price target of $60.38. Rallies surfaces BTSG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns BTSG stock?

Hedge funds tracked by Rallies that own BTSG include Farallon Capital, Soros Fund, and Orbimed Advisors. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for BrightSpring Health Services, Inc. Common Stock.

BTSG Key Metrics

Key financial metrics for BTSG
Metric	Value
Price	$58.92
Market Cap	$10.89B
P/E Ratio	38.48
EPS	$1.52
Dividend Yield	0.00%
52-Week High	$59.00
52-Week Low	$14.03
Volume	420
Avg Volume	0
Revenue (TTM)	$13.65B
Net Income	$308.71M
Gross Margin	12.18%

Top Hedge Funds Holding BTSG

Farallon Capital holds 1.62M shares of BTSG, changed +7250.00% as of Mar 31, 2026.
Soros Fund holds 1.10M shares of BTSG, changed +0.00% as of Mar 31, 2024.
Orbimed Advisors holds 497.80K shares of BTSG, changed +1.90% as of Mar 31, 2026.

Latest BTSG News

BrightSpring slides as investors lock in gains after Q1 beat-and-raise surge — May 5, 2026
BrightSpring stock climbs after Q1 beat and higher 2026 guidance raise outlook — May 4, 2026
BrightSpring Q1 Revenue Up 26% as Specialty Scripts Jump 30%, Acquisitions Add $79M — May 2, 2026
BrightSpring jumps after Q1 beat and higher 2026 revenue, EBITDA guidance — May 1, 2026
BrightSpring Health Services Q1 Revenue Up 25.6%, Adjusted EBITDA Up 44.8%, Raises Guidance — May 1, 2026

Recent BTSG Insider Trades

Nalley Lisa A sold 30.00K (~$1.23M) on Mar 4, 2026.
ROUSSEAU JON B sold 220.00K (~$9.05M) on Mar 4, 2026.
Phipps Jennifer A sold 35.00K (~$1.44M) on Mar 4, 2026.

BTSG Analyst Consensus

14 analysts cover BTSG: 0 strong buy, 14 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $60.38.

Common questions about BTSG

Who owns BTSG stock?: Hedge funds tracked by Rallies that own BTSG include Farallon Capital, Soros Fund, and Orbimed Advisors. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for BrightSpring Health Services, Inc. Common Stock.
Does Rallies show 13F holders for BTSG?: Yes. Rallies tracks hedge fund and 13F ownership data for BTSG, including fund names, share counts, latest tracked quarter, and position changes when available.
Is BTSG research on Rallies investment advice?: No. Rallies provides research, data, and educational context for BTSG. It does not provide personalized investment advice.